Macrophage PD-L1 Loss Reduces CD80 Surface Expression
A new study in Frontiers in Oncology reveals that PD-L1 deletion or blockade in macrophages consistently reduces surface levels of ...
A new study in Frontiers in Oncology reveals that PD-L1 deletion or blockade in macrophages consistently reduces surface levels of ...
A narrative review argues that safety data from six phase 3 immunotherapy trials in resectable lung cancer may not transfer ...
A new review maps how circulating tumor cells survive immune attack in the bloodstream and outlines what evidence is still ...
A new review synthesizes evidence that DNA methylation, chromatin and non-coding RNA changes reshape immune and stromal cells in the ...
A new review maps how engineered DNA and RNA aptamers could enable targeted delivery and tumor microenvironment remodeling in precision ...
A meta-analysis of six randomized trials found that adding PD-1/PD-L1 inhibitors to chemotherapy was associated with longer progression-free and overall ...
Long-term results from the phase 2 NICHE-2 trial show that none of 111 patients with dMMR colon cancer treated with ...
An international research team reports that the sphingosine-1-phosphate signaling long thought to operate inside colorectal cancer cells instead builds an ...
New research in Nature Aging shows that accelerated loss of naive CD8+ T cells in middle-aged male mice shrinks lymph ...
A phase II pilot trial found that a single fecal microbiota transplantation combined with atezolizumab and bevacizumab was safe and ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine